Severity: Warning
Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
Filename: helpers/my_audit_helper.php
Line Number: 176
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3122
Function: getPubMedXML
File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global
File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword
File: /var/www/html/index.php
Line: 316
Function: require_once
Background: The 2017 American hypertension guidelines [American College of Cardiology/American Heart Association (ACC/AHA)] define a blood pressure measurement (BPM) procedure that differs from the Canadian Hypertension Education Program (CHEP) guidelines. We studied the impact of the BPM procedure on arterial hypertension (AHT) prevalence rate.
Methods: In 805 subjects, the mean of the first and second BPM (adapted ACC/AHA procedure) was compared with the mean of the second and third BPM (CHEP procedure). All BPMs were taken at a single occasion. According to ACC/AHA definition, office blood pressure (OBP) of <120/80 mm Hg was classified as normal, 120-129/<80 mm Hg as elevated, and ≥130/80 mm Hg as hypertensive.
Results: Using the adapted ACC/AHA BPM procedure compared to the CHEP BPM procedure led to an increase in the AHT prevalence rate (≥130/80 mm Hg) of 4% (58% vs. 54%). Overall, 8.9% (72/805) of subjects were reclassified to a higher and 2.6% (21/805) to a lower blood pressure category when using the adapted ACC/AHA BPM procedure instead of the CHEP BPM procedure. In the group with elevated OBP (120-129/<80 mm Hg), 41.9% (36/86) of subjects were reclassified.
Conclusions: Minimal changes of BPM procedures lead to relevant changes of hypertension prevalence.
Clinical Trials Registration: Trial Number NCT02552030.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1093/ajh/hpy159 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!